SCHEMBL4448484

SCHEMBL4448484

CN(C)CCNCCCc1cc(-c2cccc(C(F)(F)F)c2)nc(C#N)n1

nearest known ligand 0.76

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CTSK P43235 20/20 0.76
KCNH2 Q12809 15/20 0.76
CTSS P25774 5/20 0.72
CTSB P07858 4/20 0.72
CTSL P07711 3/20 0.72
CYP1A2 P05177 1/20 0.64
CYP3A4 P08684 1/20 0.64
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4452251 0.94 CTSK (0.73) CTSKKCNH2CTSSCTSBCTSL
SCHEMBL4442212 0.87 CTSK (0.80) CTSKKCNH2CTSSCTSBCTSL
SCHEMBL4442540 0.86 CTSK (0.85) CTSKKCNH2CTSSCTSBCTSL
SCHEMBL4447914 0.86 CTSK (1.00) CTSKKCNH2CTSSCTSBCTSL
SCHEMBL4450291 0.85 CTSK (0.76) CTSKKCNH2CTSSCTSBCTSL
SCHEMBL4443979 0.84 CTSK (0.75) CTSKKCNH2CTSSCTSBCTSL
SCHEMBL4447870 0.84 CTSK (1.00) CTSKKCNH2CTSSCTSBCTSL
SCHEMBL4444295 0.83 CTSK (0.81) CTSKKCNH2CTSSCTSBCTSL
SCHEMBL4444132 0.82 CTSK (1.00) CTSKKCNH2CTSSCTSBCTSL
SCHEMBL4453801 0.82 CTSK (0.81) CTSKKCNH2CTSSCTSBCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7589095-B2 4-phenyl-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2009-09-15 US claimed
EP-1758870-B1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES ORGANON NV (NL) 2008-08-13 EP claimed
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives Cai, Jiaqiang 2008-04-17 US claimed
EP-1758870-A1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. Organon (NL) 2007-03-07 EP claimed
WO-2005121106-A1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. ORGANON (NL) 2005-12-22 WO claimed
US-7589095-B2 4-phenyl-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2009-09-15 US disclosed
EP-1758870-B1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES ORGANON NV (NL) 2008-08-13 EP disclosed
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives Cai, Jiaqiang 2008-04-17 US disclosed
EP-1758870-A1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. Organon (NL) 2007-03-07 EP disclosed
WO-2005121106-A1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. ORGANON (NL) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives P2RY4, P2RX4, P2RY1 CTSK 1852/4885KCNH2 2293/4885CTSS 2645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.